Antiemetics: all 820 studies that test it

Page 2 of 9. Open to participants first (71), then studies with results posted, then the rest; newest registration first within each.

• Effects of Ondansetron Dose and Timing on Post-operative Nausea and VomitingCompletedNCT03297021Phase 4Results posted
• Does IV Ondansetron Prevent Pruritus After Intrathecal Morphine in Pediatric Patients?TerminatedNCT03262038Phase 4Results posted
• Nabilone in Cannabis Users With PTSDTerminatedNCT03251326Phase 1/2Results posted
• Effects of Ondansetron in Obsessive-compulsive and Tic DisordersCompletedNCT03239210Phase 4Results posted
• Low Dose Aprepitant for Patients Receiving CarboplatinTerminatedNCT03237611Phase 2Results posted
• Metoclopramide for Post Traumatic HeadacheCompletedNCT03220958Phase 3Results posted
• PK/PD Study of Netupitant and Palonosetron in Pediatric Patients for Prevention of Chemotherapy-induced Nausea and VomitingCompletedNCT03204279Phase 2Results posted
• Effect of Fosaprepitant on Motor Evoked and Somatosensory Evoked Potentials Under General AnesthesiaCompletedNCT03197064Phase 4Results posted
• Netupitant and Palonosetron Hydrochloride in Preventing Chemotherapy Induced Nausea and Vomiting in Patients With Cancer Undergoing BEAM Conditioning Regimen Before Stem Cell TransplantCompletedNCT03097588Phase 2Results posted
• Metoclopramide for Post-Traumatic Headache. A Pilot StudyCompletedNCT03056352Phase 1/2Results posted
• Netupitant and Palonosetron Hydrochloride in Preventing Chronic Nausea and Vomiting in Patients With CancerCompletedNCT03040726Phase 2/3Results posted
• Quality of Recovery After Dexamethasone, Ondansetron or Placebo Intrathecal Morphine AdministrationCompletedNCT03035942Phase 4Results posted
• Scopolamine Patch Pharmacokinetics in Healthy AdultsCompletedNCT03029650Phase 4Results posted
• Haloperidol With or Without Chlorpromazine in Treating Delirium in Patients With Advanced, Metastatic, or Recurrent CancerActive, not recruitingNCT03021486Phase 2/3Results posted
• Rolapitant as an Antiemetic in Malignant Glioma Patients Receiving Radiotherapy and TemozolomideCompletedNCT02991456Phase 2Results posted
• Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of GastroparesisCompletedNCT02970968Phase 2Results posted
• Scopolamine Patch and Acupressure Point P6 Stimulation for Reduction of Nausea and Vomiting During Cesarean SectionCompletedNCT02960113Phase 4Results posted
• Assessment of Intra-subject Variability in the Bioavailability of Chlorpromazine HydrochlorideCompletedNCT02943213Phase 1Results posted
• Aprepitant- and Olanzapine- Containing Anti-emetic Regimens With High Dose MelphalanCompletedNCT02939287Phase 3Results posted
• TAK-071 Scopolamine-Induced Cognitive Impairment StudyTerminatedNCT02918266Phase 1Results posted
• CSF Pharmacokinetics of OndansetronCompletedNCT02901054Not applicableResults posted
• Comparative Study of Superficial Cervical Plexus Block and Nerve of Arnold Block and Incidence of PONV for Inner Ear SurgeryTerminatedNCT02724033Phase 4Results posted
• Role of Pepsin Assay in Wheezy InfantsCompletedNCT02685436Phase 4Results posted
• Tradipitant in Treatment-resistant Pruritus Associated With Atopic DermatitisCompletedNCT02651714Phase 2Results posted
• Effectiveness of Triple Therapy With Palonosetron for PON ProphylaxisCompletedNCT02635828Phase 4Results posted
• Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) ProphylaxisCompletedNCT02625181Not applicableResults posted
• Postoperative Nausea and Vomiting: Ramosetron Plus Aprepitant vs Palonosetron Plus AprepitantCompletedNCT02597907Not applicableResults posted
• An Efficacy and Safety Study of Intravenous Palonosetron Administered as an Infusion and as a Bolus for the Prevention of Nausea and VomitingCompletedNCT02557035Phase 3Results posted
• Efficacy and Safety Study of Fosaprepitant (MK-0517) Plus Ondansetron Versus Ondansetron Alone for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Participants (MK-0517-044)TerminatedNCT02519842Phase 3Results posted
• PEP uP Protocol in Surgical PatientsTerminatedNCT02459275Phase 4Results posted
• Granisetron Transdermal Patch for Prevention of Postoperative Nausea and VomitingCompletedNCT02457195Phase 2Results posted
• Scheduled Prophylactic Antiemetics for Reduction of Emesis With Doxycycline (SPARED) TrialCompletedNCT02456662Not applicableResults posted
• Hydromorphone Versus Prochlorperazine + Diphenhydramine for Acute MigraineCompletedNCT02389829Phase 4Results posted
• Pharmacogenetic Study of Ondansetron in Alcohol Use DisorderCompletedNCT02354703Phase 2Results posted
• Evaluation of Green Tea as Antioxidant Agent in Management of Oral Lichen PlanusCompletedNCT02329600Phase 3Results posted
• A Cost Effective Treatment for Headache in Pregnancy When Acetaminophen Alone is Ineffective.CompletedNCT02295280Not applicableResults posted
• Pharmacological Treatment of Comorbid Alcohol and Marijuana Withdrawal and DependenceCompletedNCT02210195Phase 2Results posted
• Comparison of Gabapentin and Metoclopramide for Treating Hyperemesis GravidarumCompletedNCT02163434Phase 2Results posted
• Pharmacokinetic and Efficacy Profile Intranasal Scopolamine SprayTerminatedNCT02155309Phase 2/3Results posted
• Effect of Chronic ACE and DPP4 Inhibition on Blood PressureCompletedNCT02130687Not applicableResults posted
• Pilot Study of Olanzapine and Aprepitant to Prevent Nausea and Vomiting in Children Receiving ChemotherapyCompletedNCT02097823Phase 2Results posted
• Ondansetron for Bipolar Disorder and Alcohol Use DisordersCompletedNCT02082678Phase 4Results posted
• Assessment of Single Doses of Oral Dexanabinol in Healthy SubjectsCompletedNCT02054754Phase 1Results posted
• Roflumilast and Donepezil to Reverse Scopolamine Induced Cognitive Deficits in Healthy AdultsCompletedNCT02051335Phase 1Results posted
• Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Men With Diabetic GastroparesisCompletedNCT02025751Phase 3Results posted
• Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Women With Diabetic GastroparesisCompletedNCT02025725Phase 3Results posted
• Ondissolve in the Prophylaxis/Rescue of Radiation Induced Nausea and VomitingCompletedNCT02006056Phase 2Results posted
• Proof of Concept of VLY-686 in Subjects With Treatment-Resistant Pruritus Associated With Atopic DermatitisCompletedNCT02004041Phase 2Results posted
• Sancuso® for Gastroparesis: An Open Label Study.CompletedNCT01989221Phase 3Results posted
• Can Ondansetron Prevent Neonatal Abstinence Syndrome (NAS) in Babies Born to Narcotic-dependent WomenCompletedNCT01965704Phase 2Results posted
• Topical Aprepitant in Prurigo PatientsCompletedNCT01963793Phase 2Results posted
• Gastroesophageal Reflux Treatment in SclerodermaCompletedNCT01878526Phase 3Results posted
• Fosaprepitant for N/V With High-dose Interleukin-2 for Metastatic Melanoma and Renal Cell CarcinomaTerminatedNCT01874119Phase 2Results posted
• Emergency Department (ED) Drug Interaction in Emergency Department PatientsCompletedNCT01859715Not applicableResults posted
• Differentiating the Effects of Substance P and Beta-endorphinCompletedNCT01854177Not applicableResults posted
• The Effect of Ondansetron on Cardiac Output in Elective Cesarean DeliveriesCompletedNCT01841606Phase 2Results posted
• How Pregnant Women and Their Babies Metabolize Ondansetron Compared to a Group of Non-pregnant WomenCompletedNCT01801475Phase 1/2Results posted
• Fosaprepitant + 5HT3 Receptor Antagonists + Dexamethasone in Germ Cell TumorsCompletedNCT01736917Phase 2Results posted
• A Study to Evaluate Aprepitant for the Prevention of Post-Operative Nausea and Vomiting in Children (MK-0869-219)CompletedNCT01732458Phase 2Results posted
• Domperidone for the Treatment of Chronic Nausea and Vomiting Secondary to GastroparesisCompletedNCT01711918Not applicableResults posted
• Study of the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Fosaprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Children (MK-0517-029)CompletedNCT01697579Phase 2Results posted
• Ondansetron Versus Palonosetron Antiemetic Regimen Prior to Highly Emetogenic Chemotherapy(HEC)CompletedNCT01640340Not applicableResults posted
• A Korean Study of Efficacy and Safety of Aprepitant-based Triple Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in the First Cycle of Moderately Emetogenic Chemotherapy (Non-doxorubicin Hydrochloride [Adriamycin] and Cyclophosphamide Regimens) (MK-0869-225) (KMEC)CompletedNCT01636947Phase 4Results posted
• Study to Evaluate the Efficacy of Oral Dissolving Metoclopramide Before Video Capsule EndoscopyTerminatedNCT01631994Not applicableResults posted
• Study of Metoclopramide in Small Bowel Capsule EndoscopyCompletedNCT01630109Phase 4Results posted
• Prochlorperazine Versus Acetaminophen, Aspirin, and Caffeine for the Treatment of Acute MigraineTerminatedNCT01629329Phase 4Results posted
• Effect of Neurokinin-1 Receptor (NK1R) Antagonism on Pruritus in Patients With Sezary SyndromeTerminatedNCT01625455Phase 4Results posted
• Treatment for Cannabis Withdrawal and DependenceCompletedNCT01611948Phase 2Results posted
• Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-Induced Nausea and Vomiting (MK-0517-031)CompletedNCT01594749Phase 3Results posted
• The Role of Substance P on Perception of Breathlessness During Resistive Load BreathingCompletedNCT01580423Not applicableResults posted
• 5HT3 Antagonists to Treat Opioid Withdrawal and to Prevent the Progression of Physical DependenceCompletedNCT01549652Not applicableResults posted
• Oral Ondansetron Versus Transdermal Granisetron (Sancuso) for Women With Cervical, Endometrial or Vaginal Cancer Receiving Pelvic ChemoradiationCompletedNCT01536392Phase 3Results posted
• Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Chemotherapy and Radiation Therapy for Pancreatic CancerCompletedNCT01534637Phase 2Results posted
• Enhancing Breast Milk Production With Domperidone in Mothers of Preterm NeonatesCompletedNCT01512225Phase 2Results posted
• Reletex Versus Standard of Care Therapy for Post-Operative Nausea Control in Patients Undergoing Foregut SurgeryCompletedNCT01510379Not applicableResults posted
• Fosaprepitant Dimeglumine in Preventing Nausea and Vomiting in Patients With Gastrointestinal Cancer Receiving Combination ChemotherapyCompletedNCT01504711Not applicableResults posted
• Treatment on Iatrogenic Weight Gain and Dyslipidaemia Associated With OlanzapineTerminatedNCT01491490Phase 2Results posted
• Fosaprepitant in Patients Receiving Ifosfamide-based RegimenCompletedNCT01490060Not applicableResults posted
• A Phase 1 Study of Dexanabinol in Patients With Advanced Solid TumoursCompletedNCT01489826Phase 1Results posted
• Aprepitant Versus Ondansetron in Preoperative Triple-therapy Treatment of Nausea and VomitingCompletedNCT01474915Phase 4Results posted
• Emend and Ondansetron Compared to Ondansetron Alone to Prevent CINV in Glioma Patients Receiving TemozolomideCompletedNCT01450826Phase 2Results posted
• Meclizine as a Potential Smoking Cessation TreatmentCompletedNCT01443858Phase 2Results posted
• Efficacy and Safety of Palonosetron Intravenous in Prevention of Chemotherapy Induced Nausea and Vomiting in Pediatric PatientsCompletedNCT01442376Phase 3Results posted
• Fosaprepitant Versus Aprepitant in the Prevention of Chemotherapy Induced Nausea and VomitingCompletedNCT01432015Phase 4Results posted
• Droperidol Versus Metoclopramide + Diphenhydramine for the Treatment of Primary HeadachesTerminatedNCT01406860Not applicableResults posted
• Fosaprepitant (MK-0517, EMEND® IV) In Salvage Treatment of Chemotherapy-Induced Vomiting (MK-0517-030)TerminatedNCT01405924Phase 2Results posted
• Safety and Efficacy of Palonosetron IV to Prevent Postoperative Nausea and Vomiting in Pediatric PatientsCompletedNCT01395901Phase 3Results posted
• Palonosetron, Ondansetron, and Dexamethasone for Delayed Nausea and Vomiting in Autologous Transplant PatientsCompletedNCT01370408Phase 2Results posted
• An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and VomitingCompletedNCT01363479Phase 3Results posted
• A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208)CompletedNCT01362530Phase 3Results posted
• Nabilone for Cannabis Dependence: A Pilot StudyCompletedNCT01347762Phase 2/3Results posted
• Aprepitant as Antiemetic Prophylaxis in Patients With Acute Myeloid Leukemia Undergoing Induction ChemotherapyCompletedNCT01334086Phase 2Results posted
• A Study of the Use of IV Scopolamine to Augment the Efficacy of Electroconvulsive Therapy (ECT)TerminatedNCT01312844Phase 2Results posted
• Incidence of Chemotherapy-Induced Nausea and Vomiting Associated With Docetaxel-Cyclophosphamide in Early Breast Cancer.CompletedNCT01298193Phase 4Results posted
• Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian CancerTerminatedNCT01275664Not applicableResults posted
• Valproate Versus Ketorolac Versus MetoclopramideCompletedNCT01267864Phase 4Results posted
• Ondansetron, Alcohol Use, and Alcohol-Related Symptoms In HIV+ PersonsCompletedNCT01254877Phase 2Results posted
• Two Way Bioequivalence Study Under Fed ConditionsCompletedNCT01217801Phase 1Results posted
• Crossover Study Comparing Ondansetron Orally Dissolving Film Strip (ODFS) With Zofran Orally Disintegrating TabletsCompletedNCT01217190Phase 1/2Results posted
• Prevention of Intraoperative Nausea and Vomiting During Cesarean SectionCompletedNCT01216410Not applicableResults posted

← Antiemetics overview